Compared to MK-677 (ibutamoren): Ipamorelin is peptide and SC injectable with acute kinetics (~90 min), MK-677 is oral with 24h chronic kinetics complementary pharmacological tools
If you see bubbles, gently tap the side of the syringe with your fingernail
The Phase 2 obesity trial used once-weekly subcutaneous arms of 0.6 mg, 2.4 mg, 3.6 mg, or 4.8 mg, with a 20-week dose escalation followed by 26 weeks of maintenance
doi: 10.1096/fj.10-176602 4 AllinK
By combining glucagon agonism with the powerful appetite suppression and insulin-sensitizing effects of GLP-1/GIP activation, retatrutide produces a uniquely comprehensive metabolic intervention that addresses all three primary drivers of excess weight: excessive appetite, insufficient satiety, and reduced energy expenditure